Caricamento in corso... Attendere.
Profilo società
Nykode Therapeutics is a clinical-stage biopharmaceutical company, dedicated to the discovery and development of vaccines and novel immunotherapies for the treatment cancer and infectious diseases. Nykode’s modular platform technology specifically targets antigens to Antigen Presenting Cells. The Company has both cancer and infectious disease candidates in clinical trials. Nykode has several collaborations with leading biotech- and pharma companies.
Fonte:
Nykode Therapeutics ASA
-
Ultimo aggiornamento:
10/01/2023
Regulated news
Annual and interim reports
| 26/02/2025 | Nykode Therapeutics - Quarterly report Q4 2024 |
| 27/11/2024 | Nykode Therapeutics - Quarterly report Q3 2024 |
| 21/08/2024 | Nykode Therapeutics - Quarterly report Q2 2024 |
| 14/05/2024 | Nykode Therapeutics - Quarterly report Q1 2024 |
| 19/04/2024 | Nykode Therapeutics - Annual Report 2023 |
Indirizzo
Nykode Therapeutics ASA
Gaustadalléen 21
0349
Oslo
Norvegia
E-mail:
info@nykode.com
Telefono:
+47 22958193
Fonte:
Nykode Therapeutics ASA
-
Ultimo aggiornamento:
10/01/2023